Filing Overview
Registrant: Happiness Biotech Group Limited, although the request metadata identifies Paranovus Entertainment Technology Ltd.; this entity discrepancy should be verified.
Form and period: Form 6-K covering November 2020, filed November 18, 2020. The filing reports results of the annual shareholders’ meeting held November 13, 2020, for the fiscal year ending March 31, 2021.
Business and Financial Information
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, balance-sheet, or other operating financial metrics. It is limited to corporate governance and shareholder voting matters.
Annual Meeting Results
- 14,351,806 ordinary shares were represented in person or by proxy, equal to approximately 57.40% of 25,000,000 outstanding shares. A quorum was established.
- Xuezhu Wang, Wanhe Zhang, Rui Qiang, John Levy, and Wenhui Lin were elected as directors.
- The 2020 incentive plan was approved and adopted by a vote of 14,035,520 for, 260,604 against, and 55,682 abstaining.
- Executive compensation was approved on a non-binding basis by a vote of 14,253,450 for, 42,533 against, and 55,823 abstaining.
- Shareholders approved holding future non-binding advisory votes on executive compensation every three years. The vote was 13,945,415 for a three-year frequency, compared with 369,329 for one year and 27,192 for two years; 9,870 abstained.
Changes, Outlook, and Risks
The filing does not report material financial changes versus a prior period, management guidance, operating outlook, contingencies, unusual items, or specific business risks. Approval of the incentive plan may affect future equity compensation and dilution, but the filing does not state the plan’s award size or terms.
Investor Verification Items
- Verify the registrant’s identity because the filing names Happiness Biotech Group Limited while the request metadata names Paranovus Entertainment Technology Ltd.
- Review the 2020 incentive plan for authorized shares, award terms, vesting conditions, and potential dilution.
- Confirm the directors’ terms and any subsequent changes to the board.
- Refer to the company’s annual report or other filings for financial performance, liquidity, debt, cash flow, and risk disclosures not included in this 6-K.